Published in PLoS Pathog on June 12, 2014
Castanea sativa (European Chestnut) Leaf Extracts Rich in Ursene and Oleanene Derivatives Block Staphylococcus aureus Virulence and Pathogenesis without Detectable Resistance. PLoS One (2015) 1.47
Development of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway. PLoS One (2014) 1.45
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens. Chem Biol Drug Des (2015) 1.08
Competition studies confirm two major barriers that can preclude the spread of resistance to quorum-sensing inhibitors in bacteria. ACS Chem Biol (2014) 0.98
Small molecule disruption of quorum sensing cross-regulation in pseudomonas aeruginosa causes major and unexpected alterations to virulence phenotypes. J Am Chem Soc (2015) 0.96
ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation. Antimicrob Agents Chemother (2015) 0.85
A Comparative Analysis of Synthetic Quorum Sensing Modulators in Pseudomonas aeruginosa: New Insights into Mechanism, Active Efflux Susceptibility, Phenotypic Response, and Next-Generation Ligand Design. J Am Chem Soc (2015) 0.83
Flipping the switch: tools for detecting small molecule inhibitors of staphylococcal virulence. Front Microbiol (2014) 0.83
MAE4, an eLtaS monoclonal antibody, blocks Staphylococcus aureus virulence. Sci Rep (2015) 0.83
Systematic mutational analysis of the LytTR DNA binding domain of Staphylococcus aureus virulence gene transcription factor AgrA. Nucleic Acids Res (2014) 0.82
Methicillin-resistant Staphylococcus aureus adaptation to human keratinocytes. MBio (2015) 0.82
Regulation of Virulence in Staphylococcus aureus: Molecular Mechanisms and Remaining Puzzles. Cell Chem Biol (2016) 0.82
Chemical probes of quorum sensing: from compound development to biological discovery. FEMS Microbiol Rev (2016) 0.82
Potent and Selective Modulation of the RhlR Quorum Sensing Receptor by Using Non-native Ligands: An Emerging Target for Virulence Control in Pseudomonas aeruginosa. Chembiochem (2015) 0.82
Interfering with Bacterial Quorum Sensing. Perspect Medicin Chem (2016) 0.81
SarA based novel therapeutic candidate against Staphylococcus aureus associated with vascular graft infections. Front Microbiol (2015) 0.81
The Quorum Sensing Inhibitor Hamamelitannin Increases Antibiotic Susceptibility of Staphylococcus aureus Biofilms by Affecting Peptidoglycan Biosynthesis and eDNA Release. Sci Rep (2016) 0.81
Highly Stable, Amide-Bridged Autoinducing Peptide Analogues that Strongly Inhibit the AgrC Quorum Sensing Receptor in Staphylococcus aureus. Angew Chem Int Ed Engl (2016) 0.81
Serum Lipoproteins Are Critical for Pulmonary Innate Defense against Staphylococcus aureus Quorum Sensing. J Immunol (2015) 0.81
Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy. Toxins (Basel) (2016) 0.81
Quorum-sensing regulation in staphylococci-an overview. Front Microbiol (2015) 0.81
Bacterial fitness shapes the population dynamics of antibiotic-resistant and -susceptible bacteria in a model of combined antibiotic and anti-virulence treatment. J Theor Biol (2015) 0.79
Investigational drugs to treat methicillin-resistant Staphylococcus aureus. Expert Opin Investig Drugs (2015) 0.79
The Staphylococcal Biofilm: Adhesins, Regulation, and Host Response. Microbiol Spectr (2016) 0.79
Apolipoprotein B48, the Structural Component of Chylomicrons, Is Sufficient to Antagonize Staphylococcus aureus Quorum-Sensing. PLoS One (2015) 0.78
Flow Cytometry: Impact on Early Drug Discovery. J Biomol Screen (2015) 0.78
Norlichexanthone Reduces Virulence Gene Expression and Biofilm Formation in Staphylococcus aureus. PLoS One (2016) 0.77
Virulence determinants associated with the Asian community-associated methicillin-resistant Staphylococcus aureus lineage ST59. Sci Rep (2016) 0.77
Staphylococcus aureus Shifts toward Commensalism in Response to Corynebacterium Species. Front Microbiol (2016) 0.77
Unraveling the contributions of hydrogen-bonding interactions to the activity of native and non-native ligands in the quorum-sensing receptor LasR. Org Biomol Chem (2015) 0.76
Narrow-spectrum inhibitors of Campylobacter jejuni flagellar expression and growth. Antimicrob Agents Chemother (2015) 0.76
CD36 Is Essential for Regulation of the Host Innate Response to Staphylococcus aureus α-Toxin-Mediated Dermonecrosis. J Immunol (2015) 0.76
Non-Woven Polymer Nanofiber Coatings that Inhibit Quorum Sensing in Staphylococcus aureus: Toward New Non-Bactericidal Approaches to Infection Control. ACS Infect Dis (2017) 0.75
Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus Osteomyelitis. Antimicrob Agents Chemother (2016) 0.75
Staphylococcus aureus pathogenesis in diverse host environments. Pathog Dis (2017) 0.75
Identification of Ellagic Acid Rhamnoside as a Bioactive Component of a Complex Botanical Extract with Anti-biofilm Activity. Front Microbiol (2017) 0.75
Cross-Talk between Staphylococcus aureus and Other Staphylococcal Species via the agr Quorum Sensing System. Front Microbiol (2016) 0.75
Property-Guided Synthesis of Aza-Tricyclic Indolines: Development of Gold Catalysis En Route. Adv Synth Catal (2016) 0.75
Virulence Inhibitors from Brazilian Peppertree Block Quorum Sensing and Abate Dermonecrosis in Skin Infection Models. Sci Rep (2017) 0.75
Hybrid Quadrupole-Orbitrap mass spectrometry for quantitative measurement of quorum sensing inhibition. J Microbiol Methods (2016) 0.75
Novel quorum-quenching agents promote methicillin-resistant Staphylococcus aureus (MRSA) wound healing and sensitize MRSA to β-lactam antibiotics. Antimicrob Agents Chemother (2014) 0.75
Orthopaedic device-related infection: current and future interventions for improved prevention and treatment. EFORT Open Rev (2017) 0.75
Monoclonal antibodies and bacterial virulence. Virulence (2017) 0.75
Targeting quorum sensing signal biosynthesis to fight antibiotic resistant infections: Ambuic acid as a model inhibitor. Antimicrob Agents Chemother (2017) 0.75
Surface-attached molecules control Staphylococcus aureus quorum sensing and biofilm development. Nat Microbiol (2017) 0.75
Epic Immune Battles of History: Neutrophils vs. Staphylococcus aureus. Front Cell Infect Microbiol (2017) 0.75
Staphylococcus aureus infections. N Engl J Med (1998) 36.39
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev (2001) 36.00
Antibiotic resistance-the need for global solutions. Lancet Infect Dis (2013) 15.01
Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis (2006) 8.17
A genome-wide strategy for the identification of essential genes in Staphylococcus aureus. Mol Microbiol (2002) 4.26
Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med (2012) 3.65
The future of antibiotics and resistance. N Engl J Med (2013) 3.47
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest (2009) 3.24
Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol (2012) 3.21
Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol (2010) 3.12
Skin microbiota: a source of disease or defence? Br J Dermatol (2008) 2.81
Global changes in Staphylococcus aureus gene expression in human blood. PLoS One (2011) 2.61
SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res (2011) 2.46
Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc Natl Acad Sci U S A (2005) 2.30
Virulence gene expression in human community-acquired Staphylococcus aureus infection. J Infect Dis (2009) 2.24
Apolipoprotein B Is an innate barrier against invasive Staphylococcus aureus infection. Cell Host Microbe (2008) 2.20
In vitro serial passage of Staphylococcus aureus: changes in physiology, virulence factor production, and agr nucleotide sequence. J Bacteriol (2002) 2.19
Peptide signaling in the staphylococci. Chem Rev (2010) 1.89
Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect Immun (2011) 1.79
Complete and SOS-mediated response of Staphylococcus aureus to the antibiotic ciprofloxacin. J Bacteriol (2006) 1.73
Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus. J Clin Microbiol (2005) 1.65
Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol (2013) 1.60
Structure of the Staphylococcus aureus AgrA LytTR domain bound to DNA reveals a beta fold with an unusual mode of binding. Structure (2008) 1.50
Can bacteria evolve resistance to quorum sensing disruption? PLoS Pathog (2010) 1.43
Inactivation of a bacterial virulence pheromone by phagocyte-derived oxidants: new role for the NADPH oxidase in host defense. Proc Natl Acad Sci U S A (2004) 1.42
Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function. Nat Immunol (2013) 1.39
Challenges for a universal Staphylococcus aureus vaccine. Clin Infect Dis (2012) 1.36
Induction kinetics of the Staphylococcus aureus cell wall stress stimulon in response to different cell wall active antibiotics. BMC Microbiol (2011) 1.35
Acid-shock responses in Staphylococcus aureus investigated by global gene expression analysis. Microbiology (2007) 1.34
Mutations in agr do not persist in natural populations of methicillin-resistant Staphylococcus aureus. J Infect Dis (2010) 1.27
Differential recognition of Staphylococcus aureus quorum-sensing signals depends on both extracellular loops 1 and 2 of the transmembrane sensor AgrC. J Mol Biol (2008) 1.23
Attenuating Staphylococcus aureus virulence gene regulation: a medicinal chemistry perspective. J Med Chem (2013) 1.20
To treat or not to treat: adjunctive antibiotics for uncomplicated abscesses. Ann Emerg Med (2011) 1.17
Quorum-sensing agr mediates bacterial oxidation response via an intramolecular disulfide redox switch in the response regulator AgrA. Proc Natl Acad Sci U S A (2012) 1.11
Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance? Semin Immunopathol (2011) 1.06
Membrane damage elicits an immunomodulatory program in Staphylococcus aureus. PLoS Pathog (2010) 1.05
Global analysis of the Staphylococcus aureus response to mupirocin. Antimicrob Agents Chemother (2011) 1.04
Noninvasive in vivo imaging to evaluate immune responses and antimicrobial therapy against Staphylococcus aureus and USA300 MRSA skin infections. J Invest Dermatol (2010) 1.02
Targeting agr- and agr-Like quorum sensing systems for development of common therapeutics to treat multiple gram-positive bacterial infections. Sensors (Basel) (2013) 1.01
In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice. Antimicrob Agents Chemother (2012) 1.00
Staphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner. Mol Microbiol (2011) 0.99
Discovery of antivirulence agents against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2013) 0.99
Host-pathogen interactions between the skin and Staphylococcus aureus. Curr Opin Microbiol (2011) 0.99
Quo vadis quorum quenching? Curr Opin Pharmacol (2013) 0.96
Nox2 modification of LDL is essential for optimal apolipoprotein B-mediated control of agr type III Staphylococcus aureus quorum-sensing. PLoS Pathog (2013) 0.96
Symmetric signalling within asymmetric dimers of the Staphylococcus aureus receptor histidine kinase AgrC. Mol Microbiol (2009) 0.94
Quorum sensing inhibitors: how strong is the evidence? Trends Microbiol (2013) 0.92
High-content screening: flow cytometry analysis. Methods Mol Biol (2009) 0.90
Nasal carriage as a source of agr-defective Staphylococcus aureus bacteremia. J Infect Dis (2012) 0.89
Further insights into the mode of action of the lipoglycopeptide telavancin through global gene expression studies. Antimicrob Agents Chemother (2012) 0.86
Identification of a hydrophobic cleft in the LytTR domain of AgrA as a locus for small molecule interactions that inhibit DNA binding. Biochemistry (2012) 0.85
Global changes in Staphylococcus aureus gene expression in human blood. PLoS One (2011) 2.61
Staphylococcus aureus sarA regulates inflammation and colonization during central nervous system biofilm formation. PLoS One (2013) 0.85
An 18 kDa scaffold protein is critical for Staphylococcus epidermidis biofilm formation. PLoS Pathog (2015) 0.80
Insights into the Staphylococcus aureus-host interface: global changes in host and pathogen gene expression in a rabbit skin infection model. PLoS One (2015) 0.78